XML 37 R6.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
May 2025 PIPE Transaction
April 2025 PIPE Transaction
January 2024 PIPE Transaction
At The Market Sales Agreement
Common Stock
Common Stock
April 2025 PIPE Transaction
Common Stock
January 2024 PIPE Transaction
Common Stock
At The Market Sales Agreement
Additional Paid-In Capital
Additional Paid-In Capital
May 2025 PIPE Transaction
Additional Paid-In Capital
April 2025 PIPE Transaction
Additional Paid-In Capital
January 2024 PIPE Transaction
Additional Paid-In Capital
At The Market Sales Agreement
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023           45,177,730                    
Beginning balance at Dec. 31, 2023 $ 28,931         $ 4       $ 436,060         $ 3,759 $ (410,892)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Net loss (29,584)                             (29,584)
Stock-based compensation 2,750                 2,750            
Foreign exchange translation adjustment 528                           528  
Issuance of pre-funded warrants and common stock (in shares)               44,751,286 150,000              
Issuance of pre-funded warrants and common stock       $ 52,364 $ 191     $ 4         $ 52,360 $ 191    
Conversion of tranche rights liability to equity 28,396                 28,396            
Ending balance (in shares) at Mar. 31, 2024           90,079,016                    
Ending balance at Mar. 31, 2024 83,576         $ 8       519,757         4,287 (440,476)
Beginning balance (in shares) at Dec. 31, 2023           45,177,730                    
Beginning balance at Dec. 31, 2023 28,931         $ 4       436,060         3,759 (410,892)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Net loss (50,964)                              
Foreign exchange translation adjustment 23                              
Ending balance (in shares) at Jun. 30, 2024           90,079,016                    
Ending balance at Jun. 30, 2024 63,573         $ 8       521,639         3,782 (461,856)
Beginning balance (in shares) at Mar. 31, 2024           90,079,016                    
Beginning balance at Mar. 31, 2024 83,576         $ 8       519,757         4,287 (440,476)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Net loss (21,380)                             (21,380)
Stock-based compensation 1,882                 1,882            
Foreign exchange translation adjustment (505)                           (505)  
Ending balance (in shares) at Jun. 30, 2024           90,079,016                    
Ending balance at Jun. 30, 2024 $ 63,573         $ 8       521,639         3,782 (461,856)
Beginning balance (in shares) at Dec. 31, 2024 90,150,869         90,150,869                    
Beginning balance at Dec. 31, 2024 $ 18,429         $ 8       525,611         4,209 (511,399)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Net loss (25,473)                             (25,473)
Stock-based compensation 2,042                 2,042            
Foreign exchange translation adjustment (285)                           (285)  
Ending balance (in shares) at Mar. 31, 2025           90,150,869                    
Ending balance at Mar. 31, 2025 $ (5,287)         $ 8       527,653         3,924 (536,872)
Beginning balance (in shares) at Dec. 31, 2024 90,150,869         90,150,869                    
Beginning balance at Dec. 31, 2024 $ 18,429         $ 8       525,611         4,209 (511,399)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Net loss (52,293)                              
Foreign exchange translation adjustment $ (1,684)                              
Ending balance (in shares) at Jun. 30, 2025 98,650,590         98,650,590                    
Ending balance at Jun. 30, 2025 $ 33,911         $ 9       595,069         2,525 (563,692)
Beginning balance (in shares) at Mar. 31, 2025           90,150,869                    
Beginning balance at Mar. 31, 2025 (5,287)         $ 8       527,653         3,924 (536,872)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Net loss (26,820)                             (26,820)
Stock-based compensation 1,899                 1,899            
Foreign exchange translation adjustment (1,399)                           (1,399)  
Issuance of pre-funded warrants and common stock (in shares)             5,666,667                  
Issuance of pre-funded warrants and common stock   $ 60,661 $ 4,734       $ 1       $ 60,661 $ 4,733        
Exercise of pre-funded warrants (in shares)           2,613,057                    
Exercise of pre-funded warrants 0                              
Shares issued in connection with the Company's employee stock purchase plan (in shares)           219,997                    
Shares issued in connection with the Company's employee stock purchase plan $ 123                 123            
Ending balance (in shares) at Jun. 30, 2025 98,650,590         98,650,590                    
Ending balance at Jun. 30, 2025 $ 33,911         $ 9       $ 595,069         $ 2,525 $ (563,692)